Bosuvi (Bosutinib) is an oral tyrosine kinase inhibitor primarily used to treat adults with chronic myelogenous leukemia (CML) who are resistant or intolerant to other treatments. It works by inhibiting the BCR-ABL protein, which plays a critical role in the growth of cancerous cells. For detailed information on leukemia and targeted therapies, visit Mayo Clinic and WebMD. Clinical studies on Bosutinib can also be accessed via PubMed and safety updates are available at FDA.

Key Benefits & Uses

• Effective for CML: Targets BCR-ABL-positive leukemia cells.

• Alternative therapy: Suitable for patients resistant or intolerant to other treatments.

• Oral administration: Easy-to-use oral capsule formulation.

• Clinically supported: Information and studies available at Healthline and Drugs.com.

Bosuvi supports a personalized approach to managing chronic myelogenous leukemia. Global health guidance is provided by WHO.

How to Use

• Take Bosuvi exactly as prescribed by your healthcare provider.

• Swallow capsules whole with water, usually once daily with food.

• Do not crush or chew the capsules.

• For specific dosing adjustments and interactions, refer to trusted resources like Drugs.com and Mayo Clinic.

Important Safety Information

• Inform your doctor about all existing medical conditions and medications.

• Monitor for liver problems, low blood cell counts, and heart issues.

• Pregnancy and breastfeeding should be discussed with your physician.

• For comprehensive safety guidelines, visit FDA and WebMD.

Common Side Effects

• Diarrhea

• Nausea

• Vomiting

• Fatigue

• Swelling in hands or feet

Severe side effects may occur and require immediate medical attention. Up-to-date safety information is available via Healthline and WHO.

Why Choose Bosuvi (Bosutinib)?

Bosuvi offers an effective, clinically studied option for adults with chronic myelogenous leukemia, particularly for those who have not responded to other therapies. Its targeted mechanism, oral convenience, and support from extensive research make it a reliable choice. Learn more from expert sources including PubMed and FDA.